Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-25-001099
Filing Date
2025-04-16
Accepted
2025-04-16 15:49:51
Documents
1
Period of Report
2025-03-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form313531001_04162025.html 3  
1 OWNERSHIP DOCUMENT form313531001_04162025.xml 3 2319
  Complete submission text file 0000921895-25-001099.txt   3847
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 6502444990
TITAN PHARMACEUTICALS INC (Issuer) CIK: 0000910267 (see all company filings)

EIN.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O TITAN PHARMACEUTICALS, INC. 10 EAST 53RD STREET, SUITE 3001 NEW YORK NY 10022
Business Address
Jye Chay Weei (Reporting) CIK: 0002063479 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13341 | Film No.: 25842633